-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NYSE New York Stock ExchangeUSDISIN US46185L1035-
InvitaeBörse NYSE New York Stock ExchangeISIN US46185L1035 WKN: A14NKGUSDSymbol NVTA
-
InvitaeBörse Börse MünchenEURSymbol IV8
-
INVITAE CORPBörse Gettex System der Börse MünchenEURSymbol IV8
-
INVITAE CORPBörse Quotrix System der Börse DüsseldorfEURSymbol IV8
-
INVITAE CORPBörse Börse StuttgartEURSymbol IV8
-
INVITAE CORPBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol IV8
-
INVITAE CORPBörse Börse DüsseldorfEURSymbol IV8
-
EURSymbol IV8
-
EURSymbol IV8
-
MXN
-
Invitae CorporationBörse London Stock Exchange
-
ISIN US46185L1035
WKN A14NKG
Symbol NVTA
Währung
USD
Börse
NYSE New York Stock Exchange Zeitzone: Europe/Berlin
Firmenname
Invitae Corporation
Marktkapitalisierung
7.314.587.616 (+- 35%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
9.886.175.232 oder 4.743.000.000
Mitarbeiter
2.450 (+- 22%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
1.900 oder 3.000 Mitarbeiter
EBITDA -125.425.000
PEGRatio -0.51
Buchwert 3.126
Invitae outperformed den DAX um +32 % vom 12.02.2015 bis 17.06.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 24,37 EUR +2,78%
Portrait der Invitae Aktie
Das Unternehmen Invitae Corporation aus USA beschäftigt 2.450 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Gesundheitsdienstleistungen tätig.
Die Invitae Aktie konnte seit dem 12.02.2015 eine Rendite von 75% erwirtschaften.
Das Unternehmen Invitae Corporation ist nur in 7 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter Global X Telemedicine & Digital Health ETF gewichtet Invitae mit 3,53% im ETF.
Entdecke die 6 ETFs in denen Invitae Corporation am höchsten gewichtet ist Insgesamt in 7 ETFs enthalten
Dir gefallen die Informationen zu Invitae?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Invitae?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Invitae?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Invitae?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
38 News & Informationen zur Invitae Aktie
Cathie Wood’s ARK Invest Buys Over 150,000 Shares of This COVID-19 Vaccine Supplier – 24/7 Wall St.
One of Cathie Wood's ARK Invest funds bought over 150,000 shares of Pfizer on August 18.
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc. (NYSE: BIO) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) Gilead Sciences, Inc. (NASDAQ: GILD) GlaxoSmithKline plc (NYSE: GSK) Johnson & Johnson (NYSE: JNJ) Laboratory Corporation of America Holdings (NYSE: LH) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) NanoVibronix, Inc. (NASDAQ: NAOV) (announced intention to enter over-
Cathie Wood’s ARK Invest Buys Over 2.5 Million Shares of Palantir – 24
A few of Cathie Wood's ARK Invest funds bought over 2.5 million shares altogether of Palantir on August 16.
Invitae (NVTA) Reports Q2 Loss, Tops Revenue Estimates
Invitae (NVTA) delivered earnings and revenue surprises of -30.77% and 6.19%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Invitae : Reports $116.3 Million in Revenue Driven by 287,000 in Billable Volume in Second Quarter of 2021 (Form 8-K)
Invitae Reports $116.3 Million in Revenue Driven by 287,000 in Billable Volume in Second Quarter of 2021
– Increased quarterly revenue by 152% year-over-year –
… | August 3, 2021
Invitae EPS beats by $0.06, beats on revenue (NYSE:NVTA)
Invitae (NVTA): Q2 Non-GAAP EPS of -$0.85; GAAP EPS of -$0.64 beats by $0.06.Revenue of $116.31M (+151.8% Y/Y) beats by $6.57M.Reported billable volume of 287,000 in the quarter, a…
Invitae Reports $116.3 Million in Revenue Driven by 287,000 in Billable Volume in Second Quarter of 2021
/PRNewswire/ — Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced preliminary financial and operating results for the…
2 Healthcare Stocks Wall Street Predicts Will Rally by 40% or More By StockNews
2 Healthcare Stocks Wall Street Predicts Will Rally by 40% or More
Earnings Scheduled For August 3, 2021
Companies Reporting Before The Bell
• Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter.
• Stellantis …
Opko Health (OPK) Q2 2021 Earnings Call Transcript
OPK earnings call for the period ending June 30, 2021.
OPKO Health : Reports 2021 Second Quarter Business Highlights and Financial Results (Form 8-K)
OPKO Health, Inc. reports business highlights and financial results for the three months ended June 30, 2021.
Business Highlights
… | July 29, 2021
Hedge Funds Are Dumping People’s United Financial, Inc. (PBCT)
We at Insider Monkey have gone over 866 13F filings that hedge funds and prominent investors are required to file by the SEC. The 13F filings show the…
Invitae : Volpara Collaborates With Invitae Corporation, Leading Genetics Company
SEATTLE, July 22, 2021 /PRNewswire/ — Volpara Health, a global health technology software leader providing an integrated breast care platform for the delivery of… | July 22, 2021
Invitae to Announce Second Quarter 2021 Financial Results on Tuesday, August 3, 2021
/PRNewswire/ — Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its second quarter 2021 financial…
Pacific Biosciences and Invitae Announce Intent to Expand Collaboration
Collaboration to develop production-scale HiFi Sequencing platformexpected to Include technology from Omniome, Inc. Combining both highly accurate long…
Why Bionano Genomics, Invitae, and Opko Health Stocks Sank This Week
The market's pessimism about these diagnostics stocks appeared unrelated to company-specific news.
Stocks Mixed Amid Earnings Reports, Powell and PPI
Stocks Analysis by Zacks Investment Research covering: Citigroup Inc, Bank of America Corp, Halliburton Company, Wells Fargo & Company. Read Zacks Investment Research's latest article on Investing.com
3 Things About Invitae That Smart Investors Should Know
Could Invitae become the first $1 trillion market cap healthcare company?
Where Will ARK Genomic Revolution ETF Be in 5 Years?
Cathie Wood's genomics ETF is making big bets on the
Worldwide Genomic Cancer Panel and Profiling Industry to 2025 – Featuring Anchor, Bioarray Genetics and Burning Rock Among Others
DUBLIN, July 5, 2021 /PRNewswire/ — The 'Genomic Cancer Panel and Profiling Markets by Cancer, by Application, by Tissue and by Gene Type with Sc…
U.S. Non-Invasive Prenatal Testing Market Research And Outlook 2021 – Trends, Growth Opportunities, Competitive Analysis And Forecasts To 2028
DUBLIN, July 2, 2021 /PRNewswire/ — The “U.S. Non-Invasive Prenatal Testing Market Research and Outlook, 2021 – Trends, Growth Opportunities, Competitive
U.S. Non-Invasive Prenatal Testing Market Research and Outlook 2021 – Trends, Growth Opportunities, Competitive Analysis and Forecasts to 2028
/PRNewswire/ — The “U.S. Non-Invasive Prenatal Testing Market Research and Outlook, 2021 – Trends, Growth Opportunities, Competitive Analysis and Forecasts to…
Is Invitae Corp. a Good Biotech Stock to Add to Your Portfolio? By StockNews
Is Invitae Corp. a Good Biotech Stock to Add to Your Portfolio?
Invitae (NVTA) Stock Sinks As Market Gains: What You Should Know
Invitae (NVTA) closed the most recent trading day at $33.73, moving -1.03% from the previous trading session.
Hedge Funds Are Dumping Smartsheet Inc. (SMAR)
At Insider Monkey, we pore over the filings of nearly 866 top investment firms every quarter, a process we have now completed for the latest reporting…
Invitae (NVTA) Outpaces Stock Market Gains: What You Should Know
Invitae (NVTA) closed the most recent trading day at $34.25, moving +1.3% from the previous trading session.
Pharming announces completion of enrolment in Phase II/III study with leniolisib for activated PI3K delta syndrome
LEIDEN, Netherlands, June 23, 2021 /PRNewswire/ — Pharming Group N.V. ('Pharming' or 'the Company') (Euronext Amsterdam: PHARM/Nasdaq: PHAR) anno…
OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx
MIAMI, June 22, 2021 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) today announced the appointment of Katherine Stueland as President and Chief…
Invitae (NVTA) Dips More Than Broader Markets: What You Should Know
In the latest trading session, Invitae (NVTA) closed at $39.07, marking a -0.79% move from the previous day.
3 Top Healthcare Stocks to Buy in April
All three companies have enjoyed major growth catalysts since the start of 2021.
Invitae teams up with healthcare giants to develop MRD detection panel (NYSE:NVTA)
Invitae Nabs Bristol Myers Squibb, J&J, Novartis, and Roche for Acute Myeloid Leukemia Project
Those are some solid endorsements.
Why Invitae Stock Flew Higher Today
Investors appear to like the company's new collaboration with PacBio.
These 3 Big 2020 Stock Market Winners Took Big Hits Monday
Should investors be worried?
Looking Into Invitae's Return On Capital Employed
During Q3, Invitae (NYSE:NVTA) brought in sales totaling $68.73 million. However, earnings decreased 43.12%, resulting in a loss of $80.82 million. Invitae …
Tenbagger-Depot zusammenstellen: Darauf sollten Anleger achten
Es ist möglich, mit der richtigen Aktie das Vermögen um ein Vielfaches zu mehren. Doch der Aufbau eines Tenbagger-Depots sollte strategisch erfolgen.
3 Groundbreaking Genomics Stocks To Buy No
Stocks Analysis by MarketBeat.com (Sean Sechler) covering: Pacific Biosciences of California, InVitae Corp, Crispr Therapeutics AG. Read MarketBeat.com (Sean Sechler)'s latest article on Investing.com
Portfolio Manager Thinks Gene-Editing Stocks Could Outperform Tesla
Portfolio Manager Thinks Gene-Editing Stocks Could Outperform Tesla, Stocks: TSLA,EDIT,CRSP,NTLA,ARKG,PACB,FATE,NVTA,IOVA,EXAS, release date:Jan 08, 2021